RAXONE
USPTO Trademark Record · Serial No. 86524052
Trademark details
It was initially claimed by Santhera Pharmaceuticals (Schweiz) AG on 20150204.
That brand applies to the following goods and services:chemicals used in industry and science, pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss, computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dys.
Currently that trademark is represented by trademark attorney(s): Patrick J. Concannon.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the RAXONE trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
